CHO DC-SIGN-DeltaCRD cell line

Contributors

Inventor Institute
Alessandra Cambi Radboud University Medical Center
SKU: 160719
Product description: Dendritic Cell-Specific ICAM-3-Grabbing Non-Integrin (DC-SIGN; CD209) is a type II plasma membrane PRR abundantly expressed in antigen-presenting cells such as dendritic cells (DCs) and activated macrophages. As member of the C-type Lectin Receptor (CLR) family, DC-SIGN binds a plethora of pathogens, ranging from viruses like HIV-1, ebola virus, and hepatitis C virus, to larger pathogens like Mycobacterium tuberculosis and Candida albicans.
Alternate name: DC-SIGN-Î?‚”CRD
Conditional: No
Production details: CHO cell lines stably expressing DC-SIGN-Î?‚”CRD were established by Lipofectamin 2000 transfection, and were cultured in Hamâ?‚€?‚™s F-12 medium supplemented with 10% heat-inactivated FBS, 1% Antibiotic Antimycotic Solution , and 0.5â?‚€?‚‰mg/ml of the aminoglycoside antibiotic G418.
Parental cell line: CHO
Disease: HIV-1
Cat. #: 160719
Unit size: 1×10^6 cells / vial
Research Fields: Cell signaling and signal transduction; Immunology
Organism: Hamster
Tissue: Ovary
Format: Frozen
Shipping conditions: Dry ice
Growth medium: Hamâ?‚€?‚™s F-12 medium supplemented with 10% heat-inactivated FBS, 1% Antibiotic Antimycotic Solution , and 0.5â?‚€?‚‰mg/ml of the aminoglycoside antibiotic G418.

Images

View Gallery

Related Tools for Cell lines

Cat. # Tool Name
160717 CHO DC-SIGN-N80A cell line Key Info View Tool
160716 CHO DC-SIGN WT cell line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.